Clinical Spectrum of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19 Infection

Sai, Brundavanam Venkata Krishna; Kumar, Hema; Babu, Thirunavukkarasu Arun; Chaitra, Raghuvamsi; Satapathy, Diptirekha; Kalidoss, Vinoth Kumar

doi:10.1007/s12098-021-04054-3

Cited by 1 publication

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…C-Reactive protein (CRP) was elevated in 58 (74%) patients. 38 (48%) had elevated ESR [ 18 ]. Serum Ferritin, d-dimer, and LDH were elevated in 21%, 34%, and 5% respectively.…”

Section: Discussionmentioning

confidence: 99%

Clinical profile and outcome of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 infection: a single-center observational study from South India

Sai

Kumar

Babu

et al. 2023

Egypt Pediatric Association Gaz

Self Cite

View full text Add to dashboard Cite

Background Multisystem inflammatory syndrome in children (MIS-C) is a post-infectious sequelae of acute COVID-19 infection affecting children. This study was done over a period of 12 months from December 2020 to November 2021 to describe the clinical presentation, laboratory abnormalities, and outcome of children with MIS-C. Methods Seventy-eight children below 12 years of age who satisfied the WHO diagnostic criteria for MIS-C were included in the study. Clinical parameters were recorded at admission. Relevant laboratory investigations, radiological studies, and outcome were documented. Results The most commonly affected age group was 6–12 years with a female predominance. COVID RTPCR was negative in all patients. Most cases presented 2–6 weeks after the onset of acute COVID-19 infection. Lethargy, poor feeding, vomiting, abdominal pain, loose stools, cough, and cold are common symptoms of MIS-C syndrome in children and the common signs were rash, conjunctival congestion, hypotension, tachycardia, tachypnea, and hypoxemia. Gastrointestinal system was the commonly affected followed by the hepatic, renal, and cardiovascular systems. Coronary artery abnormalities were seen in 20% of cases. IVIg was the mainstay of therapy used in 95% of patients. Mortality was 1.3%. Cases responded well to IVIg and steroids. Conclusion Overall, the short-term outcome was favorable with low mortality in our study cohort. One-fifth of children had coronary artery abnormalities during acute phase underscoring the need for long-term follow-up.

show abstract

“…C-Reactive protein (CRP) was elevated in 58 (74%) patients. 38 (48%) had elevated ESR [ 18 ]. Serum Ferritin, d-dimer, and LDH were elevated in 21%, 34%, and 5% respectively.…”

Section: Discussionmentioning

confidence: 99%